Simplex Trading
INO icon

Simplex Trading’s Inovio Pharmaceuticals INO Stock Holding History

Simplex Trading’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.6K Buy
17,600
+12,500
+245% +$20.6K ﹤0.01% 6365
2025
Q4 		$8.87K Buy
5,100
+800
+19% +$1.76K ﹤0.01% 7066
2025
Q3 		$10K Buy
4,300
+2,900
+207% +$5.55K ﹤0.01% 7894
2025
Q2 		$2K Buy
+1,400
New +$2.68K ﹤0.01% 8143
2025
Q1 		– Sell
-900
Closed -$1K – 9021
2024
Q4 		$1K Sell
900
-28,400
-97% -$126K ﹤0.01% 8218
2024
Q3 		$169K Buy
29,300
+13,700
+88% +$113K ﹤0.01% 4690
2024
Q2 		$126K Sell
15,600
-14,900
-49% -$157K ﹤0.01% 5129
2024
Q1 		$423K Buy
30,500
+29,708
+3,751% +$256K ﹤0.01% 4009
2023
Q4 		$4K Buy
+792
New +$3.91K ﹤0.01% 7970
2023
Q2 		– Sell
-442
Closed -$4K – 9423
2023
Q1 		$4K Sell
442
-3,308
-88% -$56.4K ﹤0.01% 8177
2022
Q4 		$70K Sell
3,750
-600
-14% -$13.6K ﹤0.01% 5472
2022
Q3 		$90K Buy
4,350
+833
+24% +$21.3K ﹤0.01% 5664
2022
Q2 		$73K Sell
3,517
-4,108
-54% -$116K ﹤0.01% 5983
2022
Q1 		$328K Sell
7,625
-5,000
-40% -$225K ﹤0.01% 4415
2021
Q4 		$755K Sell
12,625
-7,808
-38% -$626K ﹤0.01% 3255
2021
Q3 		$2.32M Buy
20,433
+41
+0.2% +$4.11K ﹤0.01% 1971
2021
Q2 		$2.27M Buy
+20,392
New +$1.96M ﹤0.01% 2003
2021
Q1 		– Sell
-282
Closed -$3M – 9352
2020
Q4 		$3M Sell
282
-49
-15% -$6.52K ﹤0.01% 1393
2020
Q3 		$4.6M Sell
331
-278
-46% -$58K 0.01% 922
2020
Q2 		$19.7M Buy
609
+351
+136% +$56.4K 0.03% 312
2020
Q1 		$2.3M Buy
258
+242
+1,513% +$14.9K ﹤0.01% 1176
2019
Q4 		$62K Buy
16
+2
+14% +$60 ﹤0.01% 5002
2019
Q3 		$34K Buy
14
+10
+250% +$304 ﹤0.01% 5374
2019
Q2 		$14K Sell
4
-1
-20% -$40 ﹤0.01% 5890
2019
Q1 		$21K Buy
+5
New +$252 ﹤0.01% 5685
2018
Q4 		– Hold
0
– – – 6569
2018
Q3 		– Sell
-1
Closed -$5K – 7704
2018
Q2 		$5K Sell
1
-5
-83% -$276 ﹤0.01% 6706
2018
Q1 		$4K Sell
6
-2
-25% -$108 ﹤0.01% 4795
2017
Q4 		$20K Sell
8
-4
-33% -$248 ﹤0.01% 3300
2017
Q3 		$10K Sell
12
-39
-76% -$2.9K ﹤0.01% 3766
2017
Q2 		$13K Buy
51
+49
+2,450% +$4.19K ﹤0.01% 3733
2017
Q1 		$1K Sell
2
-10
-83% -$797 ﹤0.01% 5672
2016
Q4 		$5K Sell
12
-3
-20% -$271 ﹤0.01% 4350
2016
Q3 		$4K Sell
15
-1
-6% -$110 ﹤0.01% 4460
2016
Q2 		$10K Buy
16
+1
+7% +$121 ﹤0.01% 3603
2016
Q1 		$7K Buy
15
+2
+15% +$154 ﹤0.01% 3799
2015
Q4 		$28K Sell
13
-17
-57% -$1.35K ﹤0.01% 2406
2015
Q3 		$68K Buy
30
+16
+114% +$1.39K 0.01% 1749
2015
Q2 		$23K Sell
14
-1
-7% -$107 ﹤0.01% 2337
2015
Q1 		$44K Hold
15
– – 0.01% 1657
2014
Q4 		$37K Buy
+15
New +$1.83K ﹤0.01% 1582

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's INO Position: Q2 2025 in Review

Simplex Trading sold out of Inovio Pharmaceuticals (INO) in Q2 2025, closing a stake of 8,176 shares — an estimated $15.7K sold.

Simplex Trading first reported a position in INO in Q1 2015 and held it in 33 quarters. The position peaked at $497K in Q2 2020. 103 funds tracked by Wall St. Rank hold INO as of Q2 2025.

  • Simplex Trading reported no remaining Inovio Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 8,176 Inovio Pharmaceuticals shares in Q2 2025, an estimated $15.7K.
  • Simplex Trading first reported a position in Inovio Pharmaceuticals in Q1 2015 and held it in 33 quarters.
  • Simplex Trading's Inovio Pharmaceuticals position peaked at $497K in Q2 2020.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.